Zalcitabine (2′-3′-dideoxycytidine, ddC), also called dideoxycytidine, is a
nucleoside analog reverse transcriptase inhibitor (NARTI) sold under the trade ...
Easy to read patient leaflet for zalcitabine. Includes indications, proper use,
special instructions, precautions, and possible side effects.
Zalcitabine (Hivid - discontinued) is a drug prescribed to treat HIV infection.
Information includes side effects, drug interactions, dosage, and pregnancy
Jan 25, 2001 ... Approval. FDA approval of zalcitabine for use in combination with zidovudine in
adults was granted in 1992. Initial approval was based on trial ...
Jun 13, 2005 ... Zalcitabine inhibits the activity of HIV-1 reverse transcriptase (RT) both by
competing with the natural substrate dGTP and by its incorporation ...
ddC was also known as zalcitabine or dideoxycytidine. ddC was a nucleoside
analog reverse transcriptase inhibitor, or nuke. ddC was approved in 1992 as an
Find patient medical information for zalcitabine oral on WebMD including its uses
, side effects and safety, interactions, pictures, warnings and user ratings.
Zalcitabine is a dideoxynucleoside compound in which the 3'-hydroxy group on
the sugar moiety has been replaced by a hydrogen. This modification prevents ...
HIV causes acquired immune deficiency syndrome (AIDS). Zalcitabine does not
cure HIV or AIDS, but it may slow the disease process and prolong your life.
Zalcitabine is an analogue of the nucleoside deoxycytidine which, when
intracellularly converted to an active triphosphate metabolite, inhibits replication